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Abstract 
Pulmonary Embolism (PE) is a blockage of a major blood vessel in the lung, which 
commonly occurs when a blood clot that forms in the lower extremities breaks loose and 
becomes lodged in the circulatory system of the lungs. The standard medical treatment of 
patients with a PE is systemic intravenous thrombolysis; however administering a systemic 
thrombolytic agent is associated with hemorrhage risks and also the small risk of hemorrhagic 
stroke. 
One alternative to systematic intravenous thrombolysis is catheter-directed therapy 
(CDT) utilizing tissue plasminogen activator (tPA). There are multiple methods of CDT that vary 
in the process of delivery and amount ofthe lytic, as well as the number of catheters used, 
however the most effective method has not been well established. The purpose of this study is 
to compare patient outcome data regarding the use of single and dual catheter directed 
therapies and intrathrombotic and extrathrombotic lytic administration. 
A retrospective analysis of patient data was conducted on a sample of 35 patients with 
a known PE who underwent a CDT tPA administration. A point biserial test was used to evaluate 
the relationship between the two independent variables, single and dual catheter(s) and 
catheter placement (intrathrombus or proximal to the thrombus) to two dependent variables, 
duration and pulmonary artery pressure. 
The results of the test showed no significant correlation. Contingency table measures of 
association were used to examine the two independent variables and dependent variable of the 
presence of Right Ventricular Dysfunction. Results were reported as phi coefficients and 
showed no significant correlation. These findings indicate that there is not a significant 
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correlation between the independent variables and the dependent variables. Previous research 
indicates a significant decrease in mortality when the PE is detected early and the correct 
treatment is performed. This study, although limited, helps to identify best methods in the eDT 
treatment of PE. 
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Chapter 1 
The Problem 
Pulmonary Embolism (PE) is a sudden blockage of a major blood vessel in the lung, most 
commonly due to a blood clot that forms in the lower extremities, breaks loose and becomes 
lodged in the circulatory system of the lungs. If the blood clot forms in a deep vein, rather than 
a vein close to the skin, it can lead to a PE. In some cases, the clots are small with a low 
mortality rate, but they can damage the lung. However, a large clot that interrupts blood flow 
to the lung can be deadly if not treated quickly. 
Massive pulmonary embolism is a common life threatening condition. The onset of a PE 
is very rapid and may result in shock, cardiac arrest, pulmonary infarction, pleural effusion, 
pulmonary hypertension and death if it remains untreated. In the United States, an estimated 
530,000 cases of systematic PE occur and approximately 300,000 people die every year from 
acute PE (Kuo, Gould, Louie et aI., 2009). The thirty day mortality rate for massive PE is 
approaching 30%, and the presence of shock in these patients defines a three-to- seven fold 
increase in mortality, with a majority of deaths occurring in 1 hour of presentation (Banovac, 
Buckley,Kou, et aI., 2010). 
The role of the interventional radiologist continues to evolve with the role shifting from 
diagnosis to treatment of the PE. The standard medical treatment of patients with a massive PE 
is systemic intravenous thrombolysis; however administering a systemic thrombolytic agent is 
associated with major hemorrhage risks and also the small risk of hemorrhagic stroke (Kuo, 
Gould, Louie et aI., 2009). In addition, it is unclear which alternative treatment should be used 
when systemic intravenous thrombolysis is contraindicated. One alternative to systemic 
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intravenous thrombolysis is catheter-directed therapy (CDT) utilizing tissue plasminogen 
activator (tPA). There are multiple methods of CDT that vary in the process of delivery of the 
lytic, the number of catheters used and the amount of lytic delivered. One method used to 
deliver the lytic to the embolism involves embedding the catheter into the thrombosis and 
delivering a set amount of medication over a longer period of time varying from hours to days. 
Another delivery method includes using two catheters, one to deliver the lytic and one to 
mechanically break up the clot. However, the safety and efficiency of the various methods of 
CDT have not been firmly established. Cases have been documented in which patients treated 
with tPA via CDT do not improve hemodynamically and require urgent endovascular mechanical 
thrombectomy with local pharmacologic intervention (Kuo, Gould, Louie et aI., 2009). 
In cases of massive PE, interventional radiologists currently use either catheter directed 
therapy, mechanical thrombectomy; or a combination of the two, in an effort to restore 
pulmonary blood flow in a life saving effort. There is a significant decrease in mortality when 
the PE is detected early and the correct treatment is performed (Banovac, Buckley,Kou, et aI., 
2010). Therefore the purpose of this study is to compare the use of single and dual catheter 
directed therapies in terms of patient outcomes; and to compare internally embedded 
administration of tPA versus external administration of tPA in terms of patient outcomes. 
Patient outcomes will be assessed by: 1) the duration oftreatment , 2) presence of pre-
procedural right ventricular dysfunction (RVD), and 3) measurement of pre- and post-
procedural pulmonary artery (PA) pressure. 
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Review of Literature 
PE is a sudden blockage of a deep vein within the lung usually from a blood clot traveling 
from the leg. The risk factors associated with PE include increased age, obesity ( body mass 
index >30 kg/m2), recent surgery, immobilization, chronic heart disease, fracture of long bones, 
pregnancy, varicose veins and smoking >25 cigarettes per day (Banovac, BuckleY,Kou, et aI., 
2010). Currently, CT angiography is the clinically preferred modality to diagnose PE and has 
largely replaced pulmonary angiography at most institutions (Ghaye, Ghuysen, Bruyere, et 
al.,2006). Early detection is critical for accurate treatment because it allows physicians to 
decide the best treatment option based on each patient's needs (Kuo, Gould, Louie et aI., 
2009). 
The current "gold standard" for treatment of PE is anticoagulation and systemic 
thrombolytic therapy. Banovac, BuckleY,Kou, et al. (2010) report an 8% decrease in mortality 
rate in patients who have received anticoagulation and systemic treatment of PE, where as 
untreated, PE carries a 30% mortality rate. Although systemic thrombolytic therapy is the 
current gold standard, there is still a risk of hemorrhage and an increase of oral coagulant use 
post procedure (Banovac, BuckleY,Kou, et aI., 2010). 
Catheter- directed thrombolysis (CDT) is an image guided technique that is used to 
deliver the thrombolytic agent, tissue plasminogen activator (tPA), directly to the thrombus 
through an endovascular catheter. tPA was approved by the FDA in 1996 as a thrombolytic 
agent that has been effective in the breaking down of blood clots. tPA is an enzyme that 
catalyzes the conversion of plasminogen to plasmin, the major enzyme responsible for clot 
breakdown. Administration of tPA through CDT followed by an anticoagulant, such as heparin, 
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has been proven very effective in the breakdown of pulmonary emboli (Gold haber, 2001). One 
disadvantage of tPA is the increase risk of hemorrhage in the patient (Gold haber, 2001). 
An exhaustive literature search was conducted with few studies located specific to PE 
thrombolysis. The search was extended to other vascular studies in which thrombolytic agents 
were used in the treatment of occlusive disease. In a study conducted regarding thrombolysis 
for the cerebral arteries in patients with an ischemic stroke, it was found that the risk of 
hemorrhage may be increased with no intervention. But the risk of hemorrhage is also lower 
using catheter directed tPA compared to systemic treatment because the localized low doses of 
lytic avoids the potential for systemic hemorrhage complications by acting selectively at the site 
of thrombosis. (Castro, 1996). 
COT has been performed on patients with massive PE who could not tolerate systemic 
thrombolysis, patients who failed systemic thrombolysis, or in cases when there was 
insufficient time to infuse thrombolytics (Kuo, Gould, Louie et ai.,2009). COT presents the 
advantage of a more rapid resolution ofthrombi which is offundamental importance in the 
prognosis of hemodynamically unstable patients (Spanodimos, Antonatos, Sotirellos, et ai., 
2002). COT has also been proven to be useful for patients with relative contradictions to 
systemic anticoagulantive treatment, such as recent abdominal surgery, pregnancy and severe 
allergic or idiosyncratic reactions to anticoagulants (Banovac, BuckleY,Kou , et ai., 2010). 
Because the main cause of death due to massive PE is attributed to irreversible right ventricular 
failure, early revascularization of the pulmonary bed in an effort to decrease right ventricular 
afterload has been a goal of COT (Banovac, Buckley, Kou, et ai., 2010). COT also involves risks, 
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and may need to be combined with mechanical thrombectomy to increase the success rate of 
the procedure. 
The methods and delivery of the lytic to the thrombus may vary from case to case. Some 
of the methods include using a single catheter or dual catheters, as well as placing the catheter 
intrathrombic or proximal to the thrombus to deliver the lytic. After an extensive literature 
search for information on embedded catheters in the breakdown of pulmonary embolisms, 
information seemed to be only available on the use of embedded catheters in the breakdown 
of intracranial thrombosis. The use of embedded catheters for pulmonary embolisms is a 
relatively new procedure with little information reported in the current literature. However, 
there has been a proven advantage embedding catheters in intracranial catheterizations 
(Jungreis, Wechsler, & Horton, 2010). The systemic effects of the thrombolytic agents are 
minimized when the catheter is embedded into the thrombosis resulting in a decrease of 
hemorrhages when compared to systemic intravenous administration (Jungreis, Wechsler, & 
Horton,201O). Embedding the catheter into the clot requires a trained interventionalist and 
carries the usual risks associated with angiography (Jungreis, Wechsler, & Horton, 2010). 
Potential risks associated with embedding the catheter include arterial rupture, injury ofthe 
perforating artery and spasm. (Ikushima, Ohta, Hirai, et ai, 2007) 
A different type of treatment involves using dual catheters, one to deliver a lytic and 
one to break up the clot. This method has been shown effective in acute iliofemoral DVT as a 
complete or partial thrombosis (Vedantham, Milward, Cardella, et ai., 2006). This dual catheter 
directed therapy is recommended for patients who show signs of circulatory compromise ( 
Vedantham, Milward, Cardella, et ai., 2006) . 
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The Objective 
The purpose ofthis study is to: 
1. Compare patient outcome data regarding the use of single and dual catheter directed 
therapies in terms of: 
a. duration oftreatment 
b. presence of pre-procedural right ventricular dysfunction (RVD) 
c. change in systolic pulmonary artery (PA) pressure 
2. Compare patient outcome data regarding tPA administration using intrathrombic 
catheter versus catheter proximal to thrombus: 
a. duration of treatment 
b. presence of pre-procedural right ventricular dysfunction (RVD) 
c. change in systolic pulmonary artery (PA) pressure 
Hypotheses 
1. There is no relationship between the duration of the thrombolytic procedure and the 
type of catheter (single or dual tip). 
2. There is no relationship between the presence of existing right ventricular dysfunction 
(RVD) and the type of catheter (single or dual tip). 
3. There is no relationship between the change in pre and post systolic pulmonary artery 
pressure and the type of catheter (single or dual tip). 
4. There is no relationship between the duration ofthe thrombolytic procedure and 
thrombolytic agent instillation. 
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5. There is no relationship between the presence of existing right ventricular dysfunction 
(RVD) and thrombolytic agent instillation. 
6. There is no relationship between the change in pre and post systolic pulmonary artery 
pressure and thrombolytic agent instillation. 
Definitions 
tPA -a protein involved in the breakdown of blood clots. Specifically it is a serine protease 
found on endothelial cells. As an enzyme, it catalyzes the conversion of plasminogen to 
plasmin, the major enzyme responsible for clot breakdown. 
Catheter Directed Therapy or Catheter Directed Thrombolysis (COT) - an interventional 
radiology treatment that uses targeted image-guided drug delivery with specially designed 
catheters to dissolve dangerous blood clots in the lungs 
Dual Thrombolysis Catheter- Two Catheters that arrange in a coaxial fashion with inflatable 
balloons on each distal tip. The inner catheter infused the thrombolytic agent, Aspiration is 
accomplished through the outer catheter, resulting in the break up of the clot. 
Right Ventricular Dysfunction (RVD)- A condition where the right ventricles of the heart exhibit 
decreased function. Determined in this study by the hypertrophy of the right ventricle seen on 
pre-procedural CT. 
Pulmonary Artery Pressure (PAP)- The measurement of the systolic blood pressure found in 
the pulmonary artery; determined in this study directly before and after the CDT with 
catheter{s) placed directly in the pulmonary artery. 
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Chapter 2 
Methodology 
This is a retrospective analysis of an existing dataset collected by Sumit Bhatia, MD, and 
Pablo Gamboa, MD, Riverside Department of Interventional Radiology, comparing methods of 
thrombolysis and patient outcomes. This study has been approved by The Ohio State University 
Institutional Review Board. A convenience sample of 49 patients with indications for PE over 18 
years of age was analyzed regarding the CDT method and tPA administration method. 
The data set of 49 patients was randomly chosen by Sumit Bhatia, MD and Pablo 
Gamboa, MD. An Excel spreadsheet was created to record the data. Patient (coded 1-49), 
procedure, number of catheters, placement of catheter(s), pre systolic PA pressure, post 
systolic PA pressure, duration oftreatment, and complications were all recorded. The data 
contained no direct identifiers. After all data was collected some patients were eliminated 
because they did not meet requirements of established criteria. Of the 49 original patients, 14 
were eliminated due to because the patients did not have a true pulmonary embolism or they 
had developing a life threatening condition in which CDT was contraindicated. The information 
from the remaining 35 patients was analyzed using IBM SPSS Statistics 19. Descriptive 
frequencies are reported for all variables in this study. 
The first dichotomous nominal independent variable recorded for this study was single 
versus dual catheter(s), recorded as (1) single and (2) dual. The second dichotomous nominal 
independent variable recorded for this study catheter placement (intrathrombus or proximal to 
the thrombus), recorded as (1) intrathrombus and (2) proximal to the thrombus. A point bi-
serial test of significance was used to assess the relationship between the each independent 
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variable and the two dependent variables. The first dependent was the duration of treatment, 
coded as (1) less than or equal to 12 hours; (2) 13-24 hours; (3)25-36 hours; (4) 37-48 hours = 4 and (5) 
greater than or equal to 49 hours. The coding of duration was recorded in the intervals mentioned since 
most patients were checked every eight to 12 hours for change in systolic PA pressure and reduction in 
embolism size. The second dependent variable was change in systolic pulmonary arterial 
pressure, recorded as (0) no change in pressure to a change or -5mmHg, (-1) change or -5 to -15 
mmHg, (-2) change of greater than or equal to 16mmHg. 
Contingency table measures of association were used to examine the two independent 
variables and the existing presence of Right Ventricular Dysfunction (yes (1) or no (2)). Results 
were reported as phi coefficients. 
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Chapter 3 
Results 
Descriptive Data 
The sample for this study was thirty five patients with known pulmonary embolisms who 
underwent a eDT with tPA administration. All subjects underwent their eDT within a period of 
one year, and all procedures were performed at Riverside Methodist Hospital. Factors for 
exclusion for this study included age < 18 years, patients who did not have a confirmed 
diagnosis of PE, patients who only underwent heparin therapy for their pulmonary embolisms 
and patients who could not finish their eDT due to complications. 
Physician preference and size ofthe pulmonary embolism were factors used in 
determination of whether the patient received either one or two catheters and whether the 
catheter was placed intrathrombus or proximal to the thrombus to deliver the lytic. Of the 
thirty five procedures analyzed, nineteen procedures were performed utilizing a single catheter 
(54%) and sixteen procedures performed using dual catheters (46%) (Table 1). Sixteen ofthe 
subjects had their catheter(s) embedded within the thrombus (intrathrombic) for delivery of 
the lytic agent (46%); 18 of the subjects had their catheters placed proximal to the thrombus 
(51%); and one patient underwent both methods (3%) (Table 2). 
Duration ofthe procedure was coded as ~ 12 hrs = 1; 13-24 hrs = 2; 25-36 hrs = 3; 37-
48 hrs = 4; <: 49 hrs = 5 (Table 3). Six patients had eDT that lasted for less than or equal to 
twelve hours (17%), sixteen patients had eDT that lasted for a duration of 13-24 hours (46%), 
three patients had eDT that lasted for 25-36 hours (9%), four patients had eDT that lasted for 
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37-48 hours (11%), and six patients had CDT that lasted for greater than equal to 49 hours 
(17%). 
Five ofthe thirty five subjects had a history of right ventricular dysfunction (RVD) prior 
to the procedure (14%). Of the five patients with RVD, three patients had -5 or less mmHg 
change in their systolic PA pressure, one patient had a change of -l1mmHg, and the last patient 
had a change of -20 mmHg. 
Difference in systolic pulmonary arterial pressure pre and post CDT was also evaluated 
coded as (0) no change in pressure to a change or -5mmHg, (-1) change or -5 to -15 mmHg, (-2) change 
of greater than or equal to 16mmHg. Ten subjects had no change (28%) , seventeen subjects had a 
change -5 to -15 mmHg (49%), six subjects had a change of greater than or equal to -16 mmHg 
(17%) and two subjects did not receive a difference in PA pressure due to either an initial or 
final recording of PA pressure that was unable to be recorded (6%) (Table 4). All patients 
experienced a decrease in systolic PA pressure. 
Data Analysis 
1. No significant relationship was identified between the type of catheter (single or dual) and 
A. the duration of the thrombolytic procedure 
B. the presence of pre-procedural right ventricular dysfunction (RVD) 
C. the change in pre and post systolic pulmonary artery pressure 
A point bi-serial test was used to evaluate the relationship between the independent 
variable, number of catheters, and the dependent variable, duration of treatment resulting in R 
= -0.192 (Table 5). The critical value is .349 at a two-tailed test with a level of significance = 
0.05, with a magnitude of -.192 in a negative direction. (Ary, Jacobs, Razavieh, 1979). This 
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suggests a slight association with longer procedure times associated with the use of a single 
catheter. However, no significant correlation was identified between the number of catheters 
and the duration of treatment (p=0.05). 
A point bi-serial test was used to evaluate the relationship between the independent 
variable, number of catheters, and the independent variable, change in pulmonary artery 
pressure resulting in R = -.005 (p = 0.05), with a magnitude of -.005 in a negative direction. The 
results of this test showed no significant correlation between the number of catheters and the 
change in pulmonary artery pressure (Table 6). 
Contingency table measures of association were used to examine dual versus single tip 
catheters and the presence of pre procedural Right Ventricular Dysfunction. Results were 
reported as phi coefficients. Phi =.211 at a significance level of 0.05. The results of the 
contingency tables also showed no significant correlation (Table 7 & 8). 
2. No significant relationship was identified between method ofthrombolytic agent instillation 
(external or embedded) and 
A. the duration of the thrombolytic procedure 
B. the presence of pre-procedural right ventricular dysfunction (RVD) 
C. the change in systolic pre and post pulmonary artery pressure 
A point bi-serial test was used to evaluate the relationship between the independent 
variable, catheter placement, and the dependent variable, duration oftreatment resulting in an 
R = .068. This is less than the critical value of .349 for a 0.05 level of significance with a 
magnitude of .068 in a positive direction. Therefore, no significant correlation was identified 
between the placement of the catheter and the duration of treatment (Table 9). 
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A point bi-serial test was used to evaluate the relationship between the independent 
variable, catheter placement, and the dependent variable, change in systolic pulmonary artery 
pressure. The results of this test demonstrated R = -.297 with a negative direction with a 
magnitude of -.297. The results suggest a slight association noting a greater change in systolic 
PA pressure when the catheter was placed intrathrombically. However, a significant 
relationship was not identified between the placement of the catheter and the change in 
pulmonary artery pressure (Table 10). 
Contingency table measures of association were used to examine embedded catheters 
versus non-embedded catheters and the presence of pre-procedural Right Ventricular 
Dysfunction. This statistical analysis resulted in Phi =- .133, with a magnitude of -.133 in a 
negative direction, indicating no significant correlation between these variables (Table 11 & 12). 
Qualitative Data 
Ofthe 35 patients studied 25 had no noted immediate complications. Ofthe 10 
patients that did have complications five patients had post procedural pulmonary hypertension, 
two patients had mild thrombocytopenia, one patient had a significant hematoma, one patient 
had a headache (negative for intracranial hemorrhage), and one patient had left cerebral 
intracranial hemorrhage within one hour post completion oftPA and removal of catheter. Of 
the ten patients that experienced immediate complications, 70% had only a single catheter 
delivering the lytic to their pulmonary embolism. In addition, 70% of the patients experiencing 
complications also had the catheter(s) placed proximal to the thrombus to deliver the lytic. 
Please note that although the percentages are the same, the population was analyzed as a 
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separate data set for type of catheter and method of lytic administration. Therefore, the results 
yielded two distinct patient data sets specific to the independent variable. 
Limitations/ Suggestions for Further Research 
There were a few limitations to this study. The major limitation of this study included a small 
sample size. After eliminating the 14 patients that did not meet the criteria from the original 
convenience sample of 49, only 35 patients remained. This is a problem because as the sample size 
increases, the power of the statistics increases. Sample sizes of a minimum of 20 should be used when 
analyzing data using parametric statistics. Also, the sample of patients that we did study was only from 
a small period oftime, one year. A longitudinal study would provide additional data about long term 
complications, including whether presence of RVD remained or returned post procedure. Another 
limitation that was encountered was that when searching for the data, there were some instances 
where the data had not been recorded. Suggestions for further research would include a longitudinal 
study of a larger sample size, preferably with at 20-30 individuals in each group studied. 
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Discussion 
There is limited, current literature regarding effectiveness and advantages associated 
with the delivery of a lytic agent utilizing multiple catheters for pulmonary embolism. In cases 
of DVT, dual catheters used to deliver the lytic agent directly to the thrombus suggested a 
decrease the duration of the thrombolytic procedure (Vedantham, Milward, Cardella, et aI., 
2006). Although a small negative correlation is noted in this study suggesting a slight 
association with longer procedure times related to the use of a single catheter to deliver lytic to 
the thrombus, no significant correlation was identified between the number of catheters used 
and the duration of the thrombolytic procedure. 
Also, according to literature, the use of multiple catheters increases the chance of post 
procedural complications (Vedantham, Milward, Cardella, et aI., 2006). Some ofthe main 
complications associated with the use of multiple catheters include vessel spasm, incision site 
hematomas, and non-cerebral hemorrhage (Vedantham, Milward, Cardella, et aI., 2006). These 
findings were not supported by the data analyzed in this study. Out of the ten subjects that 
experienced complications, seventy percent underwent CDT with only one catheter. Also, out 
of the three patients who had catheter directed thrombolysis with two catheters and 
experienced complications, one developed mild thrombocytopenia, and the other two 
developed post procedural pulmonary hypertension. None ofthe patients experienced the 
major complications mentioned in the literature. 
Literature reviewed regarding the use of catheters embedded within the embolism 
demonstrates better outcomes when this technique is utilized in intracranial thrombolytic 
procedures (Jungreis, Wechsler, & Horton, 2010). Potential risks associated with embedding the 
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catheter include arterial rupture, injury of the perforating artery and spasm (Ikushima, Ohta, 
Hirai, et ai, 2007). The systemic effects of the thrombolytic agents are minimized when the 
catheter is embedded into the thrombosis resulting in a decrease of hemorrhages when 
compared to systemic intravenous administration (Jungreis, Wechsler, & Horton, 2010). This 
study supported the findings demonstrated by Jungreis, Wechsler, and Horton (2010). The 
analysis ofthe data collected for this study identified that 70 percent ofthe patients with 
complication had the lytic agent delivered proximal to the thrombus. Although, the 
complications recorded from this study showed there were no reported cases of artery 
perforation or spasm. Only one case of hemorrhage was reported out of all 38 cases. 
Research conducted by Castro (1999) suggested that when the catheter is embedded 
within the clot, the duration ofthe infusion should be decreased dramatically as opposed to 
infusing the thrombolytic agent through a catheter placed proximal to the clot (Castro, 1999). 
However, this study did not support Castro's (1999) findings because the analysis of the data 
indicates similar procedure times for both methods of catheter placement during thrombolysis. 
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Conclusion 
The analysis of this dataset demonstrates that all four COT options are equally effective 
in this convenience sample. The data indicates that there were no significant correlations 
identified between the independent variables of catheter placement and number of catheters 
and the dependent variables of duration oftreatment change in systolic pulmonary artery 
pressure and presence of pre-procedural right ventricular dysfunction. 
1. No significant relationship was identified between the type of catheter (single or dual) and 
A. the duration ofthe thrombolytic procedure 
B. the presence of pre-procedural right ventricular dysfunction (RVD) 
C. the change in pre and post systolic pulmonary artery pressure 
2. No significant relationship was identified between method ofthrombolytic agent instillation 
(external or embedded) and 
A. the duration of the thrombolytic procedure 
B. the presence of pre-procedural right ventricular dysfunction (RVD) 
C. the change in pre and post systolic pulmonary artery pressure 
It is important to note that the small sample size used in this study Significantly limits 
the power of the statistical analysis and the generalizability of these findings. However, these 
findings do support similar findings in current research as identified through a thorough 
literature search. The current studies indicate that there still seems to be no definitive method 
for performing catheter-directed therapy (COT). 
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Appendix 
Table 1: Frequency-Placement of the Catheter 
Frequency Percent 
Intrathrombic 16 46 
Proximal to the thrombus 18 51 
One catheter of each 1 3 
Total 35 100 
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Table 2: 
Frequency- Number of Catheters 
Frequency Percent 
Single 19 54.3 
Dual 16 45.7 
Total 35 100 
24 
Table 3: 
Frequency- Duration of COT 
Frequency Percent 
less than or equal to 12 hours 6 17.1 
13-24 hours 16 45.7 
25-36 hours 3 8.6 
37-48 hours 4 11.4 
Greater than or equal to 49 hours 6 17.1 
Total 35 100 
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Table 4: 
Frequency- Systolic Pulmonary Artery Pressure Difference 
Frequency Percent 
No Change 10 28 
Change of -5 to -15 mmHg 17 49 
Less than or equal to -16 mmHg 6 17 
Incomplete PA pressure recordings 2 6 
Total 35 100 
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Table 5: 
Correlation- Catheter Type and duration of treatment 
Duration 
Catheter Type Pearson Correlation -.192 
Sig. (2 tailed) .270 
N 35 
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Table 6: 
Correlation- Catheter Type and Systolic PA pressure difference 
PA Pressure diff 
Catheter Type Pearson Correlation -.005 
Sig. (2-tailed) .976 
N 33 
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Table 7: 
Catheter type- RVD Crosstabulation 
RVD-Yes RVD-No Total 
Catheter Type Single Count 4 15 19 
% within catheter 21.1% 78.9% 100% 
type 
%with RVD 80.0% 50.0% 54.3% 
Dual Count 1 15 16 
% within catheter 6.3% 93.8% 100.0% 
type 
%with RVD 20.0% 50.0% 45.7% 
Total Count 5 30 35 
% within catheter 14.3% 85.7% 100.0% 
type 
%with RVD 100.0% 100.0% 100.0% 
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Table 8: 
Correlation- Catheter type-RVD 
Value Approx. 5ig. 
Nominal by Nominal Phi .211 .213 
N of Valid Cases 35 
30 
Table 9: 
Correlation- Placement of Catheter and Duration 
Duration 
Placement Pearson Correlation .068 
Sig. (2 tailed) .704 
N 34 
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Table 10: 
Correlation- Placement of Catheter and Systolic PA pressure difference 
PA pressure diff 
Placement Pearson Correlation -.297 
Sig. (2 tailed) .098 
N 32 
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Table 11: 
Catheter Placement-RVD Crosstabulation 
RVD-Yes RVD-No Total 
Placement intrathrombic Count 1 11 12 
% within 8.3% 91.7% 100.0% 
placement 
%with RVD 20.0% 37.9% 35.3% 
Proximal to the Count 4 18 22 
thrombus 
% within placement 18.2% 81.8% 100.0% 
%with RVD 80.0% 62.1% 64.7% 
Total Count 5 29 34 
% within embedded 14.7% 85.3% 100.0% 
%with RVD 100.0% 100.0% 100.0% 
33 
Table 12: 
Correlation- Catheter type-RVD 
Value Approx. Sig. 
Nominal by Nominal Phi -.133 .438 
N of Va lid Cases 34 
34 
